Henderson Jeffrey William

Halozyme Therapeutics, Inc. · Director

Henderson Jeffrey William is listed in public filings as director. This Henderson Jeffrey William insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Halozyme Therapeutics, Inc. (HALO), QUALCOMM Inc (QCOM), and Becton Dickinson and Co (BDX). Investors use Henderson Jeffrey William's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Halozyme Therapeutics, Inc.HALO$398k6k sharesGrant / ExerciseMay 5, 2026$397.9K6k shares$65.87--
Halozyme Therapeutics, Inc.HALO--36.6k sharesGrant / ExerciseMay 5, 2026Disclosure amount unavailable3.8k shares----

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
QUALCOMM IncQCOM--14.6k sharesGrant / ExerciseMar 17, 2026Disclosure amount unavailable2.6k shares----
QUALCOMM IncQCOM--1.7k sharesGrant / ExerciseMar 8, 2026Disclosure amount unavailable2.4k shares----
QUALCOMM IncQCOM--12.8k sharesGrant / ExerciseMar 8, 2026Disclosure amount unavailable2.4k shares----
QUALCOMM IncQCOM$1.6M12k sharesOtherMar 8, 2026$103.0K759 shares$135.69--
Becton Dickinson and CoBDX--9.1k sharesGrant / ExerciseJan 27, 2026Disclosure amount unavailable1.1k shares----
Halozyme Therapeutics, Inc.HALO$345k5.8k sharesGrant / ExerciseMay 1, 2025$345.2K5.8k shares$60.03--
Halozyme Therapeutics, Inc.HALO--32.8k sharesGrant / ExerciseMay 1, 2025Disclosure amount unavailable4.2k shares----
Halozyme Therapeutics, Inc.HALO$1.7M28.8k sharesSellApr 28, 2025$259.3K4.3k shares$60.34--
Halozyme Therapeutics, Inc.HALO$1.7M28.6k sharesSellApr 28, 2025$12.2K200 shares$61.00--
Halozyme Therapeutics, Inc.HALO$2.1M33.1k sharesSellApr 1, 2025$32.2K503 shares$64.05--
Halozyme Therapeutics, Inc.HALO$2.0M33.6k sharesSellMar 3, 2025$189.5K3.2k shares$59.12--
Halozyme Therapeutics, Inc.HALO$2.1M36.8k sharesSellMar 3, 2025$104.0K1.8k shares$57.93--
Becton Dickinson and CoBDX$1.9M8k sharesBuyFeb 10, 2025$350.4K1.5k shares$233.62--
Becton Dickinson and CoBDX--6.5k sharesGrant / ExerciseJan 28, 2025Disclosure amount unavailable930 shares----